首页 › 基金 › Ramiah Investment Group › BIIB
Ramiah Investment Group 对 BIIB 的持仓历史
BIOGEN INC · 医疗保健
Ramiah Investment Group 在 Q3 2026 的 13F 申报中披露持有 BIIB(BIOGEN INC)1,994 股,市值约 US$450K,约占其申报组合的 0.35%,在其申报持仓中市值排名第 40 位。 Ramiah Investment Group 最近 10 个申报季度中有 6 个季度披露了 BIIB 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Ramiah Investment Group 对 BIIB 的持仓演变
Ramiah Investment Group 于 Q2 2024 首次披露 BIIB 持仓:3,536 股(约 US$820K)。 在 6 次申报中,Ramiah Investment Group 2 次增持、2 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 1,994 股、市值约 US$450K,环比减持 -91 股。。 持仓曾出现大幅变动:Q3 2024 减持约 36% (随后一个季度股价下跌 21%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 3.54K | $819.72K | 新进 |
| Q3 2024 | 2.25K | $436.92K | 减持 |
| Q4 2024 | 2.49K | $381.38K | 增持 |
| Q1 2025 | 3.07K | $420.51K | 增持 |
| Q2 2026 | 2.08K | $450.49K | 新进 |
| Q3 2026 | 1.99K | $450.40K | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BIIB 与 13F 数据
BIIB(BIOGEN INC)属于医疗保健行业。我们追踪的基金中还有 20 只申报持有 BIIB,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$3.43B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Ramiah Investment Group
常见问题
How long has Ramiah Investment Group held BIIB?
Ramiah Investment Group has disclosed BIIB holdings in 6 of the last 10 reported quarters, going back to Q2 2024.
What is Ramiah Investment Group's current position in BIIB?
As of Q3 2026, Ramiah Investment Group holds 1.99K shares of BIIB (BIOGEN INC), valued at $450.40K, representing 0.35% of its reported portfolio and ranking #40.
Has Ramiah Investment Group been buying or selling BIIB?
In the latest 13F filing (Q3 2026), Ramiah Investment Group reduced its position in BIIB.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.